CAN
HQL
Claraphi Advisory Network’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-16,146
| Closed | -$319K | – | 321 |
|
|
2020
Q4 | $319K | Buy |
16,146
+1,528
| +10% | +$30.2K | 0.09% | 200 |
|
|
2020
Q3 | $257K | Buy |
14,618
+519
| +4% | +$9.13K | 0.09% | 189 |
|
|
2020
Q2 | $253K | Buy |
14,099
+10,332
| +274% | +$185K | 0.11% | 190 |
|
|
2020
Q1 | $56K | Buy |
+3,767
| New | +$56K | 0.03% | 447 |
|
|
2019
Q4 | – | Sell |
-10,039
| Closed | -$152K | – | 282 |
|
|
2019
Q3 | $152K | Sell |
10,039
-27,210
| -73% | -$412K | 0.09% | 222 |
|
|
2019
Q2 | $628K | Sell |
37,249
-2,013
| -5% | -$33.9K | 0.37% | 61 |
|
|
2019
Q1 | $673K | Sell |
39,262
-23,092
| -37% | -$396K | 0.42% | 50 |
|
|
2018
Q4 | $942K | Sell |
62,354
-4,280
| -6% | -$64.7K | 0.72% | 28 |
|
|
2018
Q3 | $1.36M | Buy |
66,634
+4,765
| +8% | +$97.3K | 0.76% | 25 |
|
|
2018
Q2 | $1.16M | Sell |
61,869
-140,499
| -69% | -$2.64M | 0.75% | 29 |
|
|
2018
Q1 | $3.89M | Sell |
202,368
-14,990
| -7% | -$288K | 2.76% | 3 |
|
|
2017
Q4 | $4.27M | Buy |
+217,358
| New | +$4.27M | 3.31% | 3 |
|